In a mouse model of AIS, a low-dose local arterial infusion of 20% human serum albumin solution was shown to significantly reduce the cerebral infarct volume and alleviate the neurological dysfunction caused by middle cerebral artery occlusion (11). This evidence concerns the gene ALB and androgen insensitivity syndrome.